New Zealand King Salmon's (NZK) 1H23 pro-forma EBITDA result was slightly below our expectations, mostly due to higher than expected costs which included lingering effects from the 2022 summer mortality event
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.